Joyzyme Group Limited (HKG:8622)
0.3500
+0.0050 (1.45%)
At close: Mar 10, 2026
Joyzyme Group Market Cap
Joyzyme Group has a market cap or net worth of 180.42 million as of March 10, 2026. Its market cap has increased by 0.14% in one year.
Market Cap
180.42M
Enterprise Value
144.75M
Revenue
28.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since December 13, 2018, Joyzyme Group's market cap has decreased from 188.00M to 180.42M, a decrease of -4.03%. That is a compound annual growth rate of -0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 180.42M | -19.54% |
| Dec 31, 2025 | 224.23M | 198.69% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 690.88M |
| China NT Pharma Group Company | 492.20M |
| Wai Yuen Tong Medicine Holdings | 365.66M |
| Regent Pacific Group | 262.63M |
| Shenzhen Neptunus Interlong Bio-technique Company | 246.67M |
| Tianda Pharmaceuticals | 212.85M |
| Extrawell Pharmaceutical Holdings | 198.90M |
| PuraPharm Corporation | 176.57M |